Industry Pulse

Pharmedi Vietnam (Pharmed & Healthcare Vietnam) is the largest and most influential international exhibition in the field of pharmaceuticals and healthcare in Vietnam. Officially supported by the Ministry of Health and the Ministry of Industry and Trade, the event serves as a comprehensive platform for showcasing the latest in medical equipment, pharmaceutical technologies, healthcare solutions, and biotechnological innovations.

Choosing the right peptide synthesizer isn’t about having the most advanced machine—it’s about matching the instrument to your current and future needs, ensuring flexibility, cost-effectiveness, and regulatory compliance.

With its full-spectrum product line, asynchronous multi-channel technology, high-throughput design, intelligent compliance control, and localized, competitive support, Dilunbio delivers a compelling value proposition for end-to-end peptide synthesis—from bench discovery to industrial production.

CPHI Americas is not a peptide synthesizer-specific event—but it is highly relevant:

It hosts a Machinery & Technology zone, ideal for showcasing peptide synthesis hardware.

 Its BioProduction zone gathers key stakeholders in biopharma manufacturing.

The event structure supports both exhibition and thought-leadership opportunities, with strong networking and buyer attendance.

CPHI Middle East is scheduled to take place 11–13 May 2026 at the Riyadh Exhibition and Convention Centre in Saudi Arabia. Over the years, it has grown into the largest and most influential pharmaceutical trade event in the Middle East and Africa.

In 2024, China's pharma exports showed scale expansion, structural optimization, and diversified market development. As the pharma industry internationalizes and develops with high quality, innovative and biopharmaceuticals are driving export growth, with overseas models diversifying. With emerging markets rising, the export potential of China's pharma products will be further unlocked, bringing greater market opportunities to pharma companies. As one of China's core pharma industry expos, CPHI & PMEC Shenzhen 2025 will be held in early September in Shenzhen. Themed "Bay Area Synergy—Building a Global Biopharma Resilience Ecosystem", it aligns with national policies in medicine, biotech, and AI + technology. Based in Shenzhen, it radiates across the Greater Bay Area and globally, offering a high - quality platform for the international pharma industry chain. The expo focuses on the Southeast Asian pharma market's international layout, analyzing regional pharma trade trends and investment opportunities. It will cover the entire Asia - Pacific region and the Belt and Road areas, focusing on new drug R & D, smart manufacturing, and process innovation. Gathering cutting - edge industry forces, it showcases innovative achievements and solutions, and collaboratively outlines a new blueprint for the Greater Bay Area's pharma industry.

As the global pharmaceutical industry continues to restructure and regional cooperation deepens, Asia, particularly South Korea, is gradually becoming an important growth pole for biopharmaceuticals and health technology. CPHI Korea 2025, which will be held in August 2025, is not only a regional exhibition but also an important window for observing pharmaceutical innovation trends in Asia.